Omega Healthcare Investors is one of the largest healthcare real estate investment trusts, with skilled nursing and assisted living properties in the United States, the United Kingdom, and Canada. REIT valuations hinge on property cash flows, so investors focus on FFO, FAD, and operator rent coverage rather than standard earnings per share. This quarter's results provide a useful check on the stability of Omega's tenant base amid ongoing labor and occupancy challenges. They also highlight progress in shifting toward RIDEA operating structures, which introduce new revenue streams alongside added operational complexity.
For the third quarter ended September 30, 2026, adjusted FFO reached $0.82 per diluted share, slightly ahead of the Visible Alpha consensus of $0.81 and higher than $0.79 in the same period last year. Funds available for distribution came in at $0.78 per share, topping the $0.77 estimate and the prior year's $0.75. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Total revenue rose to $340.55 million from $311.59 million a year earlier. The figure included $30.76 million in resident fees and services revenue with no year-ago counterpart, reflecting faster adoption of RIDEA structures. Rental income declined to $252.80 million from $260.74 million as the portfolio continues its transition. Lower interest expense of $44.5 million versus $58.1 million a year ago provided additional support. On the back of these results, management lifted its full-year 2026 adjusted FFO guidance to $3.28 to $3.30 per share, five cents higher at the midpoint than the earlier $3.22 to $3.26 range. Operator coverage stayed solid, with trailing twelve-month EBITDARM coverage at 2.03x and EBITDAR coverage at 1.67x as of June 30, 2026.
Investor reaction to the third-quarter report was measured yet positive. Shares moved modestly higher in after-hours trading after the announcement, as the beats on adjusted FFO and FAD, along with the raised guidance, reinforced confidence in the cash-flow outlook. Record-low leverage and the steady $0.68 quarterly dividend added further support. Key points of attention remain the drop in traditional rental income, the durability of RIDEA-related revenue, and the trajectory of operator rent coverage as skilled nursing operators manage staffing and reimbursement pressures.
Investors will watch whether Omega can maintain FAD growth while absorbing a larger RIDEA portfolio. The raised guidance points to continued momentum through the end of 2026, though the staying power of resident fees and services revenue will require close monitoring. Operator health stays central to the thesis. Improving occupancy and coverage metrics suggest a stabilizing tenant base, but labor availability and Medicaid rates will continue to affect rent coverage reliability. Capital allocation is another focus area. Management expects further accretive investments through the rest of 2026 and into early 2027, with year-to-date activity near $1.5 billion. The impact of these moves on leverage, FAD per share, and the dividend will influence sentiment in coming quarters.
In my own research process, I find Tickeron’s AI Screener helpful for quickly filtering healthcare REITs and other sectors by fundamentals, technical patterns, and AI signals. It allows me to compare metrics like FFO growth and coverage ratios across peers without spending hours on manual screens, which keeps the focus on what matters most for long-term holdings.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for OHI moved out of oversold territory on October 08, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 18 similar instances when the indicator left oversold territory. In 15 of the 18 cases the stock moved higher. This puts the odds of a move higher at 83%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on OHI as a result. In 67 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for OHI just turned positive on October 15, 2026. Looking at past instances where OHI's MACD turned positive, the stock continued to rise in 40 of 54 cases over the following month. The odds of a continued upward trend are 74%.
OHI moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for OHI crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 22 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
Following a +0.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where OHI advanced for three days, in 204 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OHI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.
OHI broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for OHI entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. OHI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 53 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.642) is normal, around the industry mean (3.125). P/E Ratio (16.549) is within average values for comparable stocks, (28.561). Projected Growth (PEG Ratio) (0.490) is also within normal values, averaging (1.649). Dividend Yield (0.058) settles around the average of (0.049) among similar stocks. OHI's P/S Ratio (11.468) is slightly higher than the industry average of (6.013).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry PublishingBooksMagazines